Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00014287
Status:
WITHDRAWN
Last Update Posted:
2013-12-19
First Post:
2001-04-10
Brief Title:
Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer
Sponsor:
University of Pittsburgh
Organization:
University of Pittsburgh
Organization Data
Organization:
University of Pittsburgh
Class:
OTHER
Study ID:
99-039
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Pittsburgh
Lead Sponsor Class:
OTHER
Responsible Party:
Laura A Pollice
Responsible Party Title:
Clinical Research Manager
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Pittsburgh
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |